Showing 2981-2990 of 10546 results for "".
The Importance of Link Building for your Practice
https://practicaldermatology.com/topics/practice-management/the-importance-of-link-building-for-your-practice/18554/The link-building discussion is sometimes confusing, but link building is never a waste of time. They add value to content and build credibility of content. Links from quality sources promote content, boost traffic, and build visibility. This Ekwa.com Ekwa educational video explains why link-buildinHow to Optimize Twitter for your Practice
https://practicaldermatology.com/topics/practice-management/how-to-optimize-twitter-for-your-practice/18558/Twitter offers practices numerous opportunities to derive great business value. It's essential to identify specific conversations, and then use the information to optimize marketing in targeted areas. This Ekwa.com Marketing Educational video explains how dermatology practices can use Twitter to effRisk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHORProtecting Assets in a Divorce
https://practicaldermatology.com/topics/practice-management/protecting-assets-in-a-divorce/18771/Statistics show that half of marriages end in divorce. Financial consequences can be significant. OJM Group principal David Mandell, JD, MBA, discusses how physicians can protect their assets in the pre-marital and the marital stages in the event of a divorce. Always contact local counsel before taOtezla Approved for Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/dermiretv-otezla-approved-for-plaque-psoriasis/19031/In this week's edition of DermWireTV from the publishers of Practical Dermatology® magazine and DermWire.com, a look at Celgene's Otezla for psoriasis--the first PDE4 inhibitor approved for plaque psoriasis. Plus, Ranbaxy's new dosage strengths of Absorica (isotretinoin), and Galderma's search for pHIPAA Update
https://practicaldermatology.com/topics/practice-management/hipaa-update/19115/Michael J. Sacopulos, JD, Founder and President of Medical Risk Institute talks about recent changes to HIPAA and their possible implications for aesthetic medicine and cosmetic surgery practices. From Vegas Cosmetic Surgery.NPS and Your Practice
https://practicaldermatology.com/topics/practice-management/nps-and-your-practice/19226/Ekwa Marketing explains NPS (net promoter survey) to doctors, dentists and other medical professionals.Harmony XL, Dr. Manjoney
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/harmony-xl-dr-manjoney-/19236/Laser skin treatment, Harmony XL. Dr. Manjoney tells us why her patients love the Harmony XL from Alma Lasers. http://www.AlmaLasers.comHarmony XL, Dr. Rullan
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/harmony-xl-dr-rullan/19237/Laser treatment, Harmony XL. Dr. Rullan shares the many uses of the Harmony XL from Alma Lasers. http://www.AlmaLasers.comMastering Business of Aesthetics
https://practicaldermatology.com/topics/practice-management/mastering-business-of-aesthetics/19270/Dr. Dayan on Success from Failure at MBA Symposium